General Manager Brian Morrissey discuss his company’s acquisition of fellow Beta-Lactam manufacturer Athlone Laboratories and its implications for an evolving industry.
This webinar will discuss three core techniques to optimise drug development through assessment of a material’s stability, composition, impurities, humidity effects, and thermal properties.
Sartorius BIA Separations illustrates a promising alternative approach for efficient lentiviral vector purification that delivers a scalable, GMP-ready biomanufacturing solution.
During this virtual panel, industry experts will discuss practical examples and considerations for transforming manufacturing processes.
EPR’s 2026 pharma manufacturing trends report covers the key developments in supply chain, quality, drug development, new modalities and beyond.
Dave Elder reflects on the array of applications for AI to facilitate successful drug development, though proof remains elusive.